Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

All roads lead to COPD… or not?

Alvar Agusti, Rosa Faner
European Respiratory Journal 2023 62: 2301470; DOI: 10.1183/13993003.01470-2023
Alvar Agusti
1Cathedra Salut Respiratoria, University of Barcelona, Barcelona, Spain
2Pulmonary Service, Respiratory Institute, Clinic Barcelona, Barcelona, Spain
3Fundació Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), Barcelona, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aagusti@clinic.cat
Rosa Faner
1Cathedra Salut Respiratoria, University of Barcelona, Barcelona, Spain
3Fundació Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), Barcelona, Spain
4Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER), Barcelona, Spain
5Immunology Unit, Department of Biomedicine, University of Barcelona, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

Traditionally, COPD has been understood to be a self-inflicted disease caused by tobacco smoking, occurring in old, “susceptible” males and characterised by an accelerated decline of lung function with age [1, 2]. Yet, our understanding of the pathogenesis of COPD has changed very significantly over the past few years [3–6] and, as a result, it is now defined as a heterogeneous condition that results from gene (G)–environment (E) interactions occurring over the lifetime (T) of the individual (GETomics) that can damage the lungs and/or alter their normal development/ageing process [7]. As a result of this new understanding, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recognises the existence of a pre-COPD condition that identifies “… individuals of any age, with respiratory symptoms and/or other detectable structural (e.g. emphysema) and/or functional abnormalities (e.g. hyperinflation, reduced lung diffusing capacity, or rapid [lung function] decline), in the absence of airflow obstruction on post-bronchodilator spirometry […]. These patients may (or not) develop persistent airflow obstruction (i.e. COPD) over time” [7]. GOLD 2023 also recognises the category of PRISm (Preserved Ratio (hence no airflow obstruction) with Impaired Spirometry) [8] which may (or may not) develop chronic airflow limitation (CAL) over time [7]. Understanding better which pre-COPD patients eventually develop CAL (or PRISm) may allow earlier and more effective preventive and management interventions [9–12].

Tweetable abstract

M.J. Divo and co-workers have developed and validated a Simple, Low cost and easy to IMplement (SLIM) calculator of the risk of developing incident chronic airflow limitation in middle-aged, ever-smokers with normal spirometry https://bit.ly/3sOqtaU

Footnotes

  • Conflict of interest: A. Agusti reports grants (paid to institution) from GSK and AstraZeneca, consulting fees from GSK, AstraZeneca, Chiesi, Menarini and Sanofi, payment or honoraria for lectures, presentations, manuscript writing or educational events from GSK, AstraZeneca, Chiesi, Menarini and Zambon, and is the chair of the board of directors of GOLD (unpaid). R. Faner reports grants from GSK, Menarini, AstraZeneca and Chiesi, consulting fees from AstraZeneca, and payment or honoraria for lectures, presentations, manuscript writing or educational events from AstraZeneca, Chiesi and Menarini.

  • Support statement: This work was supported, in part, by ISC-iii-FEDER (PI18/1008, PI21/00735, PMP21/00090), the European Research Council (ERC, PredictCOPD, 101044387), SEPAR, Menarini and the Serra Hunter programme.

  • Received August 31, 2023.
  • Accepted September 5, 2023.
  • Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 62 Issue 3 Table of Contents
European Respiratory Journal: 62 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
All roads lead to COPD… or not?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
All roads lead to COPD… or not?
Alvar Agusti, Rosa Faner
European Respiratory Journal Sep 2023, 62 (3) 2301470; DOI: 10.1183/13993003.01470-2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
All roads lead to COPD… or not?
Alvar Agusti, Rosa Faner
European Respiratory Journal Sep 2023, 62 (3) 2301470; DOI: 10.1183/13993003.01470-2023
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Tweetable abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Long-term outcome of co-infection of COVID-19 and TB
  • Leukocyte telomere length: personalised medicine for fibrotic ILD?
  • An attack of asthma is not an attack of the heart
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society